SuperworthCadre market cap CDRE
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $1.3B
- Highest close in our data
- $1.8B
- Feb 2026
Cadre is worth $1.3B at the close on Oct 23, 2026, at $29.99 a share.
That is down 27% over the last year and up 85% over five years.
Its highest close in our data was $1.8B in Feb 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.3B | $1.1B | $1.8B | −25% |
| 2025 | $1.7B | $1.1B | $1.8B | +31% |
| 2024 | $1.3B | $1.2B | $1.6B | +5% |
| 2023 | $1.2B | $702.6M | $1.2B | +64% |
| 2022 | $751.9M | $659.1M | $1.1B | −14% |
| 2021 | $874M | $664.3M | $874M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Cadre's size, closest first, today.
| Company | Market cap |
|---|---|
| CDRECadre | $1.3B |
| BVSBioventus | $1.3B |
| STAAStaar Surgical | $1.1B |
| EYENational Vision | $1.5B |
| IRMDIradimed | $1.1B |
| LMATLemaitre Vascular | $1.9B |
| INSPInspire Medical Systems | $2.1B |
| UFPTUFP Technologies | $2.3B |
| MOVMovado | $701.9M |
| MDXGMimedx | $569.9M |
| ATRCAtriCure | $3B |
| Peer median | $1.4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Cadre
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.